Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Good Publication Practice 2: updating best practice

November 13, 2008 Research and Development, Sales and Marketing GPP, Good Publication Practice, clinical trials, ethics, journals, publication

 Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
Feature

MedImmune broadens drug discovery in Cambridge

November 13, 2008 Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
News

Amgen talks up blockbuster prospects

November 12, 2008 Research and Development, Sales and Marketing Amgen

Amgen says two of its pipeline products are potential blockbusters in three indications. The company is keen to reaffirm its …
News

Patheon opens European headquarters in Switzerland

November 11, 2008 Research and Development Patheon

Contract research organisation Patheon has opened a new European head office in Zug, Switzerland, near Zurich. The new headquarters will …
News

Working Life: Viggo Birch

November 10, 2008 Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers

How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Feature

Latest news from Datamonitor

November 10, 2008 Research and Development, Sales and Marketing HRT

Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
News

Study boost for Roche’s Actemra

October 30, 2008 Research and Development, Sales and Marketing RA, Roche

New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
News

Strong results for Novartis drug in rare autoimmune disease

October 30, 2008 Research and Development, Sales and Marketing Novartis

Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …
News

Specialising for success

October 29, 2008 Research and Development, Sales and Marketing marketing, product portfolio

From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …
Feature

Working Life: Philip Sarbutt

October 28, 2008 Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing

How did you find your way into your role?
Feature

Working in vaccines, a primer

October 22, 2008 Business Services, Research and Development, Sales and Marketing Novartis, recruitment, vaccines

Feature

Leaders use war gaming to strengthen UK biotech

October 22, 2008 Research and Development, Sales and Marketing biotech

Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …
News

MedImmune opens new R&D facility in Cambridge

October 17, 2008 Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
News

Government looks to plug health research gaps

October 16, 2008 Research and Development

The government is investing £5 million in specialist research projects on the planning and provision of health services. The new …
News

Stop micro-managing CROs

October 15, 2008 Research and Development CRO, contract research, contract research organisation

Contract research organisations are now play a key role in the development of most of the industry's drugs, with some …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026